Morton Collins, Director at INOVIO PHARMACEUTICALS, INC. (INO), bought 74,600 shares at $9.45 ($710K) on 2016-04-15, disclosed to the SEC on 2016-04-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.45 | 6,200 | $59K | 8.3% |
| 2 | $9.45 | 6,200 | $59K | 8.3% |
| 3 | $9.46 | 4,200 | $40K | 5.6% |
| 4 | $9.49 | 2,000 | $19K | 2.7% |
| 5 | $9.49 | 28,000 | $266K | 37.4% |
| 6 | $9.57 | 28,000 |
| $268K |
| 37.8% |
| Total | $9.51 avg | 74,600 | $710K | 100% |
| Filing → |
| INO | BUY | 2017-03-28 | $133K | — | Filing → |
| INO | BUY | 2016-06-29 | $183K | — | Filing → |
| KOPN | BUY | 2016-05-20 | $106K | — | Filing → |